| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2021―Sep―02 |
The impact of Vaccination worldwide on SARS-CoV-2 infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants |
Douglas Henrique Pereira Damasceno, Arthur Aguiar Amaral, Cecília Andrade Silva, Ana Cristina Simões e Silva |
| 2 |
[GO] |
2021―Aug―23 |
Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) |
Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos, Hong Yu |
| 3 |
[GO] |
2021―Jul―27 |
Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2 |
Luana N. O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. dos Santos, et al. (+8) Maryelle G. de Carvalho, Eduardo M. Dalmarco, Leonardo B. Turqueti, Marcus Tullius Scotti, Luciana Scotti, Francisco F. de Assis, Antonio Braga, Louis Pergaud Sandjo |
| 4 |
[GO] |
2021―Jun―24 |
Interfering Reactive Cysteine Proteome in Covid-19 Disease |
Marcos Martinez-Banaclocha |
| 5 |
[GO] |
2021―Jun―15 |
Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects |
Davide Gentile, Vincenzo Patamia, Virginia Fuochi, Pio M. Furneri, Antonio Rescifina |
| 6 |
[GO] |
2021―May―27 |
COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota |
István Bókkon, Gábor Kapócs, András Vucskits, Attila Erdöfi-Szabó, Jan Vagedes, Felix Scholkman, Henrik Szőke |
| 7 |
[GO] |
2021―May―27 |
Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy |
Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Knaff, Volker Mailänder, Tanja Schirmeister, Christian Kersten |
| 8 |
[GO] |
2021―May―22 |
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection |
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello |
| 9 |
[GO] |
2021―May―10 |
SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies |
Zhao-Zhong Chong, Nizar Souayah |
| 10 |
[GO] |
2021―May―05 |
Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics |
Rahul Sharma, Dharmendra Khokhar, Bhanushree Gupta, Purnendu Saxena, Kallol Kumar Ghosh, Arvind Kumar Geda, Kamil Kuca |
| 11 |
[GO] |
2021―Apr―06 |
The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis |
Alice Barros Câmara, Igor Augusto Brandão |
| 12 |
[GO] |
2021―Mar―30 |
Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2 |
Walter Filgueira de Azevedo Junior, Gabriela Bitencourt-Ferreira, Joana Retzke Godoy, Hilda Mayela Aran Adriano, Wallyson André dos Santos Bezerra, Alexandra Martins dos Santos Soares |
| 13 |
[GO] |
2021―Feb―19 |
Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses |
Sathish Veerasamy, Manivannan Chandrakumar, Malathi Balasubramaniyan, Ramesh Kumar Arumugam, Thanasekaran Pounraj |
| 14 |
[GO] |
2021―Feb―15 |
Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19 |
Katharina Lanza, Raphael Dias, Rafaela dos Santos Oliveira, Luís Belotto, Aline Silva Miranda, Ana Cristina Simões e Silva |
| 15 |
[GO] |
2021―Feb―10 |
Nucleoside Inhibitors of Coronaviruses |
Anastasia A. Zenchenko, Mikhail S. Drenichev, Sergey N. Mikhailov |
| 16 |
[GO] |
2021―Jan―26 |
Natural Products as Potential Agents Against SARS-CoV and SARS-CoV-2 |
Joanda Paolla Raimundo e Silva, Chonny Alexander Herrera Acevedo, Thalisson Amorim de Souza, Renata Priscila Barros de Menezes, Zoe L. Sessions, Lucas Silva Abreu, et al. (+6) Samuel Paulo Cibulski, Luciana Scotti, Marcelo Sobral da Silva, Eugene N. Muratov, Marcus Tullius Scotti, Josean Fechine Tavares |
| 17 |
[GO] |
2021―Jan―14 |
Deep learning in the quest for compound nomination for fighting COVID-19 |
Maria Mernea, Eliza. C. Martin, Andrei-José Petrescu, Speranta Avram |
| 18 |
[GO] |
2021―Jan―08 |
Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19 |
Sumera Zaib, Nehal Rana, Areeba Noor, Imtiaz Khan |
| 19 |
[GO] |
2020―Dec―10 |
The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19 |
Ilias Giannakodimos, Georgia-Vasiliki Gkountana, Dimosthenis Lykouras, Kiriakos Karkoulias, Sotiris Tsakas |
| 20 |
[GO] |
2020―Oct―28 |
COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed. |
Nuria E. Campillo, Mercedes Jimenez, Matilde Canelles |
| 21 |
[GO] |
2020―Oct―28 |
COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases |
Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Cicero B. Mello |
| 22 |
[GO] |
2020―Oct―28 |
Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV) |
Sehrish Bano, Abdul Hameed, Mariya Al-Rashida, Shafia Iftikhar, Jamshed Iqbal |
| 23 |
[GO] |
2020―Oct―27 |
Evidence and the main adverse effects regarding drug therapies in the war against COVID-19 |
Mauricio Mora-Ramírez, Paulina Melgoza-Hernández, Sebastian Eduardo Toledo-Ramírez, Juan Manuel Mejía Aranguré |
| 24 |
[GO] |
2020―Oct―06 |
COVID-19 related coagulopathy: what is known up to now |
Ana Luísa Batista Pena, Rafael Arantes Oliveira, Renata Gomes Severo, Ana Cristina Simões e Silva |
| 25 |
[GO] |
2020―Sep―09 |
Current scenario and future prospect in the management of COVID-19 |
Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, et al. (+2) Kiran Kalia, Rakesh Kumar Tekade |
| 26 |
[GO] |
2020―Sep―05 |
Targeting COVID-19 in Parkinson’s patients: Drugs repurposed. |
Firoz Anwar, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo, Mohammad Amjad Kamal |
| 27 |
[GO] |
2020―Sep―03 |
Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19 |
Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Cristina Cerqueira Vieira, Lucas Crepaldi Carvalho Nery, Raphael Figuiredo Dias, Ana Cristina Simões e Silva |
| 28 |
[GO] |
2020―Jul―22 |
Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19 |
Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha AlAdhami, et al. (+6) Madiha Chowdhury, Aqeel Imran, Ioannis Psaltis, Shirin Jamshidi, Kazi S. Nahar, Khondaker Miraz Rahman |
| 29 |
[GO] |
2020―Jul―11 |
Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions |
Anil K. Sharma, Varruchi Sharma, Arun Sharma, Suresh Pallikkuth |
| 30 |
[GO] |
2020―Jul―02 |
The chronicle of COVID-19: possible strategies to curb the pandemic |
Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew |
| 31 |
[GO] |
2020―May―13 |
In vitro data of current therapies for SARS-CoV-2 |
Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris, Nikolaos Tentolouris |
| 32 |
[GO] |
2020―Apr―16 |
SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus |
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello |
